https://www.selleckchem.com/pr....oducts/Gefitinib.htm
To the authors' knowledge, information regarding whether daily bathing with chlorhexidine gluconate (CHG) reduces central line-associated bloodstream infection (CLABSI) in pediatric oncology patients and those undergoing hematopoietic stem cell transplantation (HCT) is limited. In the current multicenter, randomized, double-blind, placebo-controlled trial, patients aged ≥2 months and 22 years with cancer or those undergoing allogeneic HCT were randomized 11 to once-daily bathing with 2% CHG-impregnated cloths or control cloths for
Curtir
Comentario
Compartilhar
